Millions of people around the world live with osteoarthritis, a condition that can make everyday activities painful and difficult.
Walking, climbing stairs, getting out of a chair, or even standing for long periods can become challenging as the disease progresses. Osteoarthritis is especially common among older adults, and it is one of the leading causes of disability worldwide.
The condition develops when the cartilage that cushions the ends of bones inside a joint gradually breaks down. Healthy cartilage allows bones to move smoothly against one another.
As the cartilage wears away, the bones begin to rub together, leading to pain, stiffness, swelling, and reduced mobility. Over time, the damage can become severe enough that surgery is needed to replace the damaged joint.
Knee and hip replacement surgeries are among the most common operations performed in older adults. While these procedures can greatly improve quality of life, they are major surgeries that require hospital stays, rehabilitation, and months of recovery. They can also be costly and carry risks such as infection, blood clots, and complications related to anesthesia.
Because of these challenges, researchers are constantly looking for treatments that might slow the progression of osteoarthritis and help people avoid surgery.
A recent study has highlighted an unexpected possibility. Researchers found that colchicine, a medication commonly used to treat gout, may help reduce the likelihood of needing knee or hip replacement surgery.
Colchicine has been used for decades to treat gout, a painful form of arthritis caused by the buildup of uric acid crystals in the joints.
The drug works by reducing inflammation and preventing damage caused by the body’s inflammatory response. Because inflammation is an important part of gout, colchicine has become a well-established and widely used treatment.
Scientists have increasingly recognized that inflammation may also play a role in osteoarthritis. Although osteoarthritis has traditionally been viewed as a condition caused mainly by wear and tear, research suggests that inflammation within the joint may contribute to cartilage damage and worsening symptoms.
This led researchers to wonder whether colchicine could help protect joints affected by osteoarthritis.
To investigate this possibility, researchers from the Netherlands carried out a large clinical study involving more than 5,500 participants from Australia and the Netherlands. The participants ranged in age from 35 to 82 years old.
The volunteers were randomly assigned to one of two groups. One group received a low daily dose of colchicine, 0.5 milligrams per day, while the other group received a placebo, which looked identical but contained no active medication. The participants were followed for an average of about 29 months.
When the researchers analyzed the results, they found a meaningful difference between the two groups. Among people taking colchicine, 2.5 percent eventually needed knee or hip replacement surgery. In the placebo group, the rate was 3.5 percent.
Although the difference may appear small, it represents a significant reduction in the risk of joint replacement surgery. The findings suggest that colchicine may help slow the progression of joint damage in some people with osteoarthritis.
The researchers also noticed an interesting pattern. The benefits appeared to be stronger in men than in women. However, the study was not specifically designed to explain why this difference occurred, and the findings for women were less certain. Additional research will be needed to better understand whether sex-related factors influence how well colchicine works.
The study provides further evidence that inflammation contributes to osteoarthritis progression. If future research confirms these findings, colchicine could become an important tool for managing the disease. Even delaying joint replacement surgery by several years could make a major difference for many patients.
One reason researchers are excited about colchicine is that it is already a well-known medication with a long history of use. Doctors are familiar with its effects, and its safety profile is generally well understood when used appropriately. This could make it easier to introduce into clinical practice if future studies continue to show benefits.
However, experts caution that the results should not be considered definitive. More studies are needed to determine which patients benefit most, how long the treatment should be used, and whether long-term use remains safe and effective for people with osteoarthritis.
For now, colchicine is not considered a standard treatment for osteoarthritis. People with joint pain should not start taking the medication without consulting their healthcare provider. Like all medications, colchicine can cause side effects and may not be suitable for everyone.
Current recommendations for managing osteoarthritis remain unchanged. Regular physical activity, maintaining a healthy body weight, protecting joints from injury, and following medical advice are still among the most effective ways to manage symptoms and slow disease progression.
Exercise is especially important because it helps strengthen the muscles that support the joints and improves flexibility and mobility.
Even so, this research offers an encouraging glimpse into a possible new treatment approach. As scientists continue to learn more about the role of inflammation in osteoarthritis, medications like colchicine may eventually become part of a broader strategy to reduce pain, preserve mobility, and help people avoid major surgery.
If you care about pain, please read studies about how to manage your back pain, and Krill oil could improve muscle health in older people.
For more health information, please see recent studies about how to live pain-free with arthritis, and results showing common native American plant may help reduce diarrhea and pain.
The study was published in the Annals of Internal Medicine.
Copyright © 2026 Knowridge Science Report. All rights reserved.
